Agenda
  • MAY 09, 2018 06:00 AM PDT
    Speaker: Justin Zook, PhD
  • MAY 09, 2018 06:00 AM PDT
    Speaker: Marcel Dinger, PhD
  • MAY 09, 2018 07:30 AM PDT
    Speaker: Cynthia Morton, PhD
  • MAY 09, 2018 09:00 AM PDT
    Sponsored By: QIAGEN
    Ina Scheuerpflug, PhD
    Director of Global Marketing, Life Science, QIAGEN
    Verena Schramm, PhD
    Global Product Manager, QIAGEN
  • MAY 09, 2018 09:00 AM PDT
    Speaker: Sigrid Reinsch, PhD
  • MAY 09, 2018 09:00 AM PDT
    Speaker: Fritz Sedlazeck, PhD
  • MAY 09, 2018 10:30 AM PDT
    Speaker: Kenneth Buetow, PhD, FACMI
  • MAY 09, 2018 10:30 AM PDT
    Speaker: Juliane Nguyen, PharmD, PhD
    Sponsored By: Nanostring Technologies
  • MAY 09, 2018 12:00 PM PDT
    Speaker: Noel Burtt
  • MAY 09, 2018 12:00 PM PDT
    Speaker: Christopher I Amos, PhD
  • MAY 09, 2018 01:30 PM PDT
    Speaker: Jessica C. Mar, PhD
  • MAY 09, 2018 01:30 PM PDT
    Sponsored By: QIAGEN
    Ulrich Broeckel, MD
    Professor of Pediatrics, Medicine and Physiology, Chief...
    Amy Turner, BS
    Research Associate I, Project Leader - miRNA Technologi...
  • MAY 10, 2018 06:00 AM PDT
    Speaker: Joseph Paulson, PhD
  • MAY 10, 2018 06:00 AM PDT
    Speaker: Kevin Roy, PhD
  • MAY 10, 2018 07:30 AM PDT
    Speaker: Katherine Blizinsky, PhD
  • MAY 10, 2018 09:00 AM PDT
    Speaker: Jonas Korlach, PhD
  • MAY 10, 2018 09:00 AM PDT
    Speaker: Steven Gross, PhD
    Sponsored By: Agilent
  • MAY 10, 2018 10:30 AM PDT
    Speaker: Chris Merritt, PhD
    Sponsored By: Nanostring Technologies
  • MAY 10, 2018 10:30 AM PDT
    Speaker: Ryan E Mills, PhD
  • MAY 10, 2018 10:30 AM PDT
    Speaker: Mark Driscoll, PhD
  • MAY 10, 2018 12:00 PM PDT
    Speaker: Amina Abubakar, PharmD, AAHIVP
  • MAY 10, 2018 01:30 PM PDT
    Speaker: Bruce R. Korf, MD, PhD
  • Structural Variation and Genetic Diversity
  • MAY 09, 2018 06:00 AM PDT
    Speaker: Justin Zook, PhD
  • MAY 09, 2018 07:30 AM PDT
    Speaker: Cynthia Morton, PhD
  • MAY 09, 2018 09:00 AM PDT
    Speaker: Fritz Sedlazeck, PhD
  • MAY 09, 2018 10:30 AM PDT
    Speaker: Kenneth Buetow, PhD, FACMI
  • MAY 09, 2018 12:00 PM PDT
    Speaker: Christopher I Amos, PhD
  • MAY 09, 2018 01:30 PM PDT
    Speaker: Jessica C. Mar, PhD
  • MAY 10, 2018 07:30 AM PDT
    Speaker: Katherine Blizinsky, PhD
  • MAY 10, 2018 10:30 AM PDT
    Speaker: Ryan E Mills, PhD
  • Genomic Medicine
  • MAY 09, 2018 06:00 AM PDT
    Speaker: Marcel Dinger, PhD
  • MAY 09, 2018 09:00 AM PDT
    Sponsored By: QIAGEN
    Ina Scheuerpflug, PhD
    Director of Global Marketing, Life Science, QIAGEN
    Verena Schramm, PhD
    Global Product Manager, QIAGEN
  • MAY 09, 2018 10:30 AM PDT
    Speaker: Juliane Nguyen, PharmD, PhD
    Sponsored By: Nanostring Technologies
  • MAY 09, 2018 12:00 PM PDT
    Speaker: Noel Burtt
  • MAY 09, 2018 01:30 PM PDT
    Sponsored By: QIAGEN
    Ulrich Broeckel, MD
    Professor of Pediatrics, Medicine and Physiology, Chief...
    Amy Turner, BS
    Research Associate I, Project Leader - miRNA Technologi...
  • MAY 10, 2018 09:00 AM PDT
    Speaker: Steven Gross, PhD
    Sponsored By: Agilent
  • MAY 10, 2018 12:00 PM PDT
    Speaker: Amina Abubakar, PharmD, AAHIVP
  • MAY 10, 2018 01:30 PM PDT
    Speaker: Bruce R. Korf, MD, PhD
  • Metagenomics
  • MAY 09, 2018 09:00 AM PDT
    Speaker: Sigrid Reinsch, PhD
  • MAY 10, 2018 06:00 AM PDT
    Speaker: Joseph Paulson, PhD
  • MAY 10, 2018 09:00 AM PDT
    Speaker: Jonas Korlach, PhD
  • MAY 10, 2018 10:30 AM PDT
    Speaker: Mark Driscoll, PhD
  • Genome Editing
  • MAY 10, 2018 06:00 AM PDT
    Speaker: Kevin Roy, PhD
  • Genomic Editing
  • MAY 10, 2018 10:30 AM PDT
    Speaker: Chris Merritt, PhD
    Sponsored By: Nanostring Technologies
MAY 9 - 10 2018

Genetics and Genomics 2018

OOPS! THAT EXPERIMENT FAILED...

It's not your fault! Something went wrong with our formula.
Please begin your experiment again by clicking here.

If this error continues to occur please contact us at support@labroots.com.

Our 6th Annual Genetics and Genomics Virtual Conference is now available On Demand!

As the foundation of life, genetics provides a base for other sciences to grow from. This free on-demand event will cover the most recent and exciting advances in genetics research.

Participants of the Genetics 2018 event will learn from renowned experts like Dr. Sigrid Reinsch from NASA's GeneLab Project, Dr. Christopher Amos from Dartmouth Geisel School of Medicine, Dr. Cynthia Morton from Harvard Medical School, Dr. Katherine Blizinsky from NIH and Dr. Fritz Sedlazeck from Baylor College of Medicine.

Topics Will Included:

  • Genome Editing
  • Metagenomics
  • Genomic Medicine
  • Structural Variation and Genetic Diversity


LabRoots invites research scientists, post-docs, principal investigators, lab directors and other genetics professionals to learn about new discoveries and discuss their own findings with like-minded colleagues and experts in the field. Genetics and Genomics conference participants benefit from interacting with field experts and networking with colleagues. Attendees can also “walk” through the virtual exhibit hall to learn about the latest in genetics and genomics tools and assays. Join LabRoots in leading progress toward understanding the genetics behind disease and treatment!

Our on-demand virtual conference allows you to participate in a global setting with no travel or cost to you. You can participate in exactly those parts which you are interested in and be back at your desk or bench in an instant. Virtual events remove time and place restrictions and ensure that everyone who wants to participate can do so. This virtual conference also offers increased reach for the global genetics community with a high degree of interaction through live-streaming video and chat sessions.

Produced on a new, more robust platform, you can watch, learn and connect during this conference on mobile devices easier than ever before. Equipped with gamification and point system, you can now move around the entire event earning points for a chance to win one of LabRoots most popular shirts


Continuing Education
By participating in this virtual event and watching webcast presentations, you can earn free CEU, PACE, and/or CME credits. To earn educational credits, you must view an entire presentation. Following the presentation, you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit. The American Board of Genetic Counseling, certifies genetic counselors and accredits genetic counseling training programs. The National Society of Genetic Counselors (NSGC) is the professional membership association for the genetic counseling profession.

Use #LRgenetics to follow the conversation!

 


Speakers
  • Policy Director, All of Us Research Program, National Institutes of Health
  • Professor, Harvard Medical School, Director of Cytogenetics, Brigham and Women's Hospital
  • CEO/President, RX Clinic Pharmacy/AVANT Institute of Clinicians
  • Associate Director for Population Sciences, Professor of Community and Family Medicine at the Geisel School of Medicine, Norris Cotton Cancer Center, Dartmouth College
  • Professor of Pediatrics, Medicine and Physiology, Chief - Section of Genomic Pediatrics, Department of Pediatrics, Medical College of Wisconsin
  • Director of Computational Sciences and Informatics program for Complex Adaptive Systems and Professor in the School of Life Sciences, Arizona State University
  • Director, Operations & Development, Knowledge Portals & Diabetes Research, Broad Institute of MIT and Harvard
  • Head, Kinghorn Centre for Clinical Genomics, Garvan Institute; CEO, Genome.One
  • Chief Scientific Officer, Co-Founder, Shoreline Biome, LLC
  • Professor of Pharmacology, Director, Advanced Training in Pharmacology, Director, Metabolomics Lab, Weill Cornell Medical College
  • Professor and Chair, Department of Genetics, Director, Heflin Center for Genomic Sciences, UAB
  • Chief Scientific Officer, Pacific Biosciences
  • Assistant Professor, Department of Systems & Computational Biology, Assistant Professor, Department of Epidemiology & Population Health, Albert Einstein College of Medicine
  • Senior Scientist at NanoString Technologies, Inc.
  • Assistant Professor, Department of Computational Medicine & Bioinformatics, Assistant Professor, Department of Human Genetics, University of Michigan
  • Assistant Professor, Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo
  • Research Fellow, Dana-Farber Cancer Institute
  • Scientist, Space Biosciences Research Branch, NASA
  • Postdoctoral Scholar, Department of Genetics, Stanford University
  • Director of Global Marketing, Life Science, QIAGEN
  • Global Product Manager, QIAGEN
  • Lead Scientific Programmer, Baylor College of Medicine
  • Research Associate I, Project Leader - miRNA Technologies, Section of Genomic Pediatrics, Department of Pediatrics, Medical College of Wisconsin
  • Research Scientist, NIST

Show Resources
Posters

POSTER SUBMISSION GUIDELINES

Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer-reviewed. Submission is free.

SUBMIT YOUR ABSTRACT

Enter the following information to this Submission Form:

  • Poster Title
  • Your Name
  • Your Institution
  • Your Email
  • Abstract describing the poster

All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

Questions? Email Posters@LabRoots.com

LabRoots Policy

Speakers

  • Katherine Blizinsky, PhD
    Policy Director, All of Us Research Program, National Institutes of Health
    Biography
      Katherine D. Blizinsky, Ph.D, is the Policy Director for the All of Us Research Program. A neuroscientist and geneticist specializing in research on mental health and cognition, with a focus on health disparities, Dr. Blizinsky completed her doctoral work at Northwestern University. She is an alumna of the American Society of Human Genetics/National Human Genome Research Institute (NHGRI) Genetics and Public Policy Fellowship and has policy experience with both the legislative and executive branches. On Capitol Hill, Dr. Blizinsky worked with the Senate Health, Education, Labor, and Pensions (HELP) Committee under Ranking Member Patty Murray, where, among other roles, Dr. Blizinsky participated in the drafting and negotiation of the 21st Century Cures Act, which became law in 2016. Following her time on the Hill, she moved to NIH, where she held simultaneous appointments as Policy Advisor to the All of Us Research Program-concentrating on issues of data access, informed consent, and participant privacy-and as an Intramural Research Fellow with the NHGRI Health Disparities Unit under Vence L. Bonham. In addition to her current positions with All of Us and continued work with the Health Disparities Unit, Dr. Blizinsky is an Assistant Professor in the Department of Neurology at Rush University and on the faculty of the Rush Alzheimer's Disease Center in Chicago, IL.
    • Cynthia Morton, PhD
      Professor, Harvard Medical School, Director of Cytogenetics, Brigham and Women's Hospital
      Biography
        Cynthia Casson Morton received her Bachelor of Science degree from the College of William and Mary in Virginia and her Ph.D. in Human Genetics from the Medical College of Virginia in Richmond. She is the William Lambert Richardson Professor of Obstetrics, Gynecology and Reproductive Biology and Professor of Pathology at Harvard Medical School, Director of Cytogenetics and Past Director of the Biomedical Research Institute at Brigham and Women's Hospital. She is an Institute Member of the Broad Institute of MIT and Harvard. Dr. Morton is an adjunct faculty member of the University of Manchester where she holds a position as Chair in Auditory Genetics. Dr. Morton is certified by the American Board of Medical Genetics in Ph.D. Medical Genetics, Clinical Cytogenetics and Clinical Molecular Genetics. Her research interests are in molecular cytogenetics, hereditary deafness, genetics of uterine leiomyomata and human developmental disorders. She has published over 275 original articles. Dr. Morton is a past member of the Board of Directors of the American Board of Medical Genetics. She was the Chair of the Molecular Genetic Pathology Policy and Exam Committees of the American Board of Medical Genetics and the American Board of Pathology. She served as Member and Chair of the Board of Scientific Counselors of the National Institute of Deafness and Other Communication Disorders, and as Member and Chair of the Board of Regents of the National Library of Medicine. Dr. Morton is currently a member of the Counsel of Scientific Trustees of the Hearing Health Foundation, and Chair of the Veteran's Administration Genomic Medicine Program Advisory Committee. Dr. Morton is a member of the Board of Directors of the American Society of Human Genetics and served as the 2014 President. She recently completed a six year tenure as Editor of The American Journal of Human Genetics and is currently Co-Editor of Human Genetics.
      • Amina Abubakar, PharmD, AAHIVP
        CEO/President, RX Clinic Pharmacy/AVANT Institute of Clinicians
        Biography
          Amina Abubakar, PharmD, AAHIVP, is the owner of Rx Clinic Pharmacy in Charlotte, NC. She graduated from the Philadelphia College of Pharmacy University of the Sciences in 2005. She is also both the founder and President of the Avant Institute of Clinical Pharmacy, where her passion for furthering the impact and success of clinical pharmacy services is realized through online learning, webinars and consultations with pharmacies across the United States. She is a clinical pharmacist, Certified HIV Specialty Pharmacist, and a preceptor to UNC Chapel Hill residents and students from several schools of pharmacy. She has fostered an environment that showcases the significance and impact of patient care of community pharmacists by collaborating with medical providers and expanding pharmacist led clinical services in her community. She serves as a board member for Pharmacogenetics Center of Excellence, a non-profit dedicated to advocacy for the profession of pharmacy in pharmacogenetics. She also serves as a Luminary for CPESN USA, where she helps other community pharmacists to facilitate the advancement of CPESN networks. Currently, she shares her experience and passion for pharmacy advancements through the Avant Institute. The institute offers online trainings as well as Advanced Learning Immersion Experience (ALIE) a simulation lab for those seeking to experience first hand pharmacist led clinical services. Amina also advocates for pharmacists by engaging with policy makers all over the country on Pharmacogenomics. She was invited to the White House Office of Science and Technology Policy and to the FDA to discuss the role of pharmacists in pharmacogenomics.
        • Christopher I Amos, PhD
          Associate Director for Population Sciences, Professor of Community and Family Medicine at the Geisel School of Medicine, Norris Cotton Cancer Center, Dartmouth College
          Biography
            Dr. Christopher Amos received his M.S. and Ph.D. degrees in 1985 and 1988 from the Louisiana State University Medical Center in New Orleans from the Department of Biometry and Genetics. In his graduate studies he developed novel approaches for conducting genetic linkage analysis for multivariate data and in extended families. Subsequently, Dr. Amos completed training in Medical Genetics through the Inter-institute training program in Genetics at the NIH (1992), where he also completed postdoctoral training in the Family Studies Section of the Environmental Epidemiology Branch at the National Cancer Institute. During this period (1988-1992), he studied inheritance patterns of breast and ovarian cancers, publishing seminal papers in the Journal of the American Medical Association and the Journal of the National Cancer Institute. He also developed a novel and widely cited approach for linkage analysis that was published in the American Journal of Human Genetics in 1994(PMID:8116623, 787 citations). He has authored or coauthored 548 peer reviewed papers, 19 reviews or book chapters, 2 books and has an H index of 104 with 43,170 citations. His work is funded by 11 current and 2 approved pending P01 grants from NIH (on one he serves as communicating PI). He has served as PI, multiple PI or core leader on 25 funded grants (including R01, U01, P01, U19, P20, P30 and T32 grants from NIH and ACS grants) and coinvestgator on an additional than 14 grants. In 1992 he was recruited to the M.D. Anderson Cancer Center where he joined the Department of Epidemiology and established the Section of Computational and Genetic Epidemiology. There he developed and applied novel bioinformatical approaches for identifying genomic factors influencing lung, breast, head and neck, colon and brain cancer development. In 1994 he received his first NIH R01 to develop model-free linkage analysis methods and develop software to support these methods. He has subsequently received several other NIH grants as PI as well as Co-Investigator that have supported the development of new statistical methods to understand the interplay of genetic and environmental factors that cause lung cancer development. He wrote a book 'Forward-Time Population Genetics Simulations: Methods, Implementation, and Applications') with coauthors Dr. Bo Peng (at M.D. Anderson Cancer Center) and Dr. Marek Kimmel (at Rice) that describes approaches to simulating populations for genetic analyses. He also led studies that recruited and studied individuals with inherited risk for lung, colon and breast cancer. In 2004, in collaboration with Dr. Joan Bailey-Wilson and others, he identified a region of chromosome 6q23-25 that harbors a locus greatly increasing lung cancer risk, and showed in 2010 that this locus identifies individuals exquisitely sensitive to tobacco smoke. This collaboration led to the discovery that mutations in Park2 increase lung cancer risk. In 2008, he led large genetic studies that identified common variants in CHRNA5 (PMID 20554942 cited 1032 times) that have substantial impact on both lung cancer risk and smoking behavior, making it more difficult for smokers to quit. Dr. Amos led an ACS funded grant to study Peutz-Jeghers syndrome a rare condition that causes greatly increased risk for breast, colon and pancreatic cancers with most cases carrying mutations in STK11. He also lead the biostatistics and bioinformatics core for Dr. Louise Strong's P01 'A mutational model for Childhood Cancers' which led to the development of novel approaches for statistical and bioinformatical analysis to identify modifiers of risk for cancer. He also led several other bioinformatical and supported database development for several large projects including the Human Pedigree Analysis Resource core of the M.D. Anderson Cancer Center Support Grant, database development for the Gliogene Consortium, led by Dr. Melissa Bondy to identify genetic factors for familial brain cancers and Bioinformatics leader for the Texas Cancer Genetics Consortium which brought together investigators from UT Southwestern, UT San Antonio, UT M.D. Anderson Cancer Center and the Baylor College of Medicine to identify high risk families with cancer for whom targeted prevention and interventions would be effective. In 2012, Dr. Amos moved to the Geisel School of Medicine at Dartmouth College where he became the inaugural Chair for the Department of Biomedical Data Science, which includes Divisions of Biostatistics, Biomedical Informatics and Behavioral Studies. The Department grew under his leadership to 24 faculty members and about 80 staff. He also heads the Center of Genomic Medicine and became the Norris Cotton Cancer Center's Associate Director for Population Studies. Dr. Amos continued the work to identify and characterize genetic factors influencing lung cancer risk. He led an international team that studied over 50,000 individuals and identified uncommon mutations in BRCA2 that confer a 250% higher risk for developing squamous lung cancer. Dr. Amos is leading an international collaboration entitled 'Transdisciplinary Research in Cancer of the Lung' that had been supported by a U19 award from the NCI, which integrates genetic studies from international sites for discovery and epidemiological analysis of lung cancer risk. Work being performed by this consortium has been organized into a P01 submission that recently was approved for funding at the NCI with an expected start date of June 1, 2017. Dr. Amos moved to the Baylor College of Medicine on November 1, 2017 where he is the Associate Director for Quantitative Research and the Director of the Institute for Clinical and Translational Research. In addition to lung cancer, Dr. Amos has been involved in cutting edge research in other malignancies. He led the OncoArray Consortium that recently completed genotyping of about 500,000 individuals using a customized array developed with Illumina that comprises 500,000 markers. It was developed to decipher the genetic architecture of common cancers including prostate, colon, breast and ovarian cancers. Managing population-based analysis of this very large study required the development of new analytical approaches for characterizing the ethnic origin of participants to avoid confounding and the approach (published in BMC Bioinformatics). Results of studies using this array have been published in Nature Genetics for Head and Neck, Glioma (led by Dr. Melissa Bondy at the Baylor College of Medicine), and Ovarian Cancer, and there are additional accepted papers forthcoming in Nature and Nature Genetics. These papers have revealed the genetic architectures and more novel variants influencing Lung cancer, and ER+ and ER- breast cancer. Since 2014, Dr. Amos has been collaborating with Drs. Hashem El-Serag at Baylor College of Medicine and Manal Hassan at the M.D. Anderson Cancer Center in the Hepatobiliary Cancer Consortium which brings together North American Investigators to understand its environmental and genetic etiologies. This research has established a national consortium to identify genetic and environmental factors contributing to the epidemic of hepatobiliary cancer. Dr. Amos leads the design and analytical team responsibilities for the consortium. At Dartmouth, Dr. Amos co-leads the New Hampshire Colonoscopy Registry. Currently, he is serving at the interim Director of the Norris Cotton Cancer Center (NCCC), an NCI-designated cancer center. He leads the Center for Genomic Medicine, which was developed in collaboration with leaders in Pathology to develop approaches for routine sequencing for cancer NCCC patients. These data have been integrated with the electronic medical record, and are being used to identify clinical characteristics of patients associated with carriage of actionable mutations. Dr. Amos is also leader in cancer research mentoring. He is director of a Center of Biomedical Research Excellence grant (P20) 'Quantitative Biomedical Research Institute' that mentors junior faculty toward their initial award of an R01, and supports bioinformatics and personalized medicine at Dartmouth College and surrounding institutions in New Hampshire, Maine and Vermont. Dr. Amos serves as leader of the Biostatistics Epidemiology and Research Design component of the Clinical and Translational Institute at Dartmouth College, and has been directing the biomedical informatics team. Finally, Dr. Amos is leading a T32 training grant funded by the Knowledge to Big Data initiative for training graduate students in biomedical data sciences. Dr. Amos's expertise is recognized nationally and internationally. Dr. Amos became the President of the International Genetic Epidemiology Society in 2002, and served as its Secretary/Treasurer from 2007 to 2012. He served on the board of external scientific advisors for the Centre Etude Polymorphism Humain from 2007-2014. He was elected as a fellow of the American Association for the Advancement of Science in 2012. He currently serves on the Board of Scientific Counselors for the National Institute of Environmental Health Sciences. He completed a term as reviewer for the Access Committee for the Center for Inherited Disease Research from 2007-2011. He has also served as a reviewer for NIH, Cancer Research UK, and Canadian Institute for Health Research and numerous other panels. He has served or is serving as an associate editor for the American Journal of Human Genetics, Genes and Immunity, Genetic Epidemiology and Human and Molecular Genetics, and as a statistical editor for the Journal of the National Cancer Institute.
          • Ulrich Broeckel, MD
            Professor of Pediatrics, Medicine and Physiology, Chief - Section of Genomic Pediatrics, Department of Pediatrics, Medical College of Wisconsin
            Biography
              Ulrich Broeckel, MD is a Professor of Pediatrics, Medicine and Physiology and the Chief of the Section of Genomic Pediatrics, at the Medical College of Wisconsin. Dr. Broeckel received his MD from the University of Heidelberg, Germany. He continued his training in internal medicine and cardiology. His research focuses on genetics of cardiovascular diseases, pediatric genetics and pharmacogenetics. His lab uses induced pluripotent stem cells to study the functional effect of genome variation. He is also the technical director of a CAP/CLIA certified clinical genetic testing laboratory.
            • Kenneth Buetow, PhD, FACMI
              Director of Computational Sciences and Informatics program for Complex Adaptive Systems and Professor in the School of Life Sciences, Arizona State University
              Biography
                Dr. Ken Buetow is a human genetics and genomics researcher who leverages computational tools to understand complex traits such as cancer, liver disease, and obesity. Dr. Buetow currently serves as Director of Computational Sciences and Informatics program for Complex Adaptive Systems at Arizona State University (CAS@ASU) and is a professor in the School of Life Sciences in ASU's College of Liberal Arts and Sciences. CAS@ASU applies systems approaches that leverage ASU's interdisciplinary research strengths to address complex global challenges. The Computational Sciences and Informatics program is developing and applying information technology to collect, connect, and enhance trans-disciplinary knowledge both within ASU and across the broader knowledge-generating ecosystems. CAS@ASU is creating a Next Generation Cyber Capability to address the challenges and opportunities afforded by "Big Data" and the emergence of 4th Paradigm Data Science. This capability brings state-of-the-art computational approaches to CAS@ASU's transdisciplinary, use-inspired research efforts Dr. Buetow previously served as the Director of the Center for Biomedical Informatics and Information Technology within the National Institutes of Health's National Cancer Institute (NCI). In that capacity he initiated and oversaw the NCI's efforts to connect the global cancer community through community-developed, standards-based, interoperable informatics capabilities that enable secure exchange and use of biomedical data. Buetow designed and built one of the largest biomedical computing efforts in the world. He was responsible for coordinating biomedical informatics and information technology at the NCI. The NCI center he led focused on speeding scientific discovery and facilitated translational research by coordinating, developing and deploying biomedical informatics systems, infrastructure, tools and data in support of NCI research initiatives.
              • Noel Burtt
                Director, Operations & Development, Knowledge Portals & Diabetes Research, Broad Institute of MIT and Harvard
                Biography
                  Noël Burtt is the Director of Operations and Development, Knowledge Portals and Diabetes, at the Broad Institute, providing organizational leadership and developing research strategies for the program. She defines and stewards new collaborations/research initiatives, identifies funding opportunities, and performs resource allocation and planning. She also oversees operations and external relations for the Accelerating Medicines Partnership for Type 2 Diabetes (AMP-T2D) Program and leads scientific operations for the AMP-T2D Data Coordinating Center. She is responsible for the continued growth of the T2D Knowledge Portal and that of the emerging Knowledge Portals for additional complex diseases. Noël began her career developing technologies for genotyping and sequencing at the Whitehead Center for Genome Research (now the Broad Institute), and transitioned into scientific project management for an array of international genome-wide association studies. Building standardized approaches to data and analysis activities, communication and data sharing, and organizational and operational procedures in order to promote collaboration has been a consistent theme throughout her career.
                • Marcel Dinger, PhD
                  Head, Kinghorn Centre for Clinical Genomics, Garvan Institute; CEO, Genome.One
                  Biography
                    Marcel Dinger is the Founding CEO of Genome.One, Head of the Kinghorn Centre for Clinical Genomics (KCCG) at the Garvan Institute of Medical Research and conjoint Associate Professor at UNSW Australia. Genome.One is a world-class clinical genomics service and develops specialist software and analytics solutions to enable precision healthcare worldwide. Genome.One was one of the first companies in the world to implement the HiSeq X Ten genome sequencing platform, which has capacity to sequence 18,000 human genomes per year, and provide a disease diagnostics service based on whole genome sequencing. He has worked in bioinformatics and genomics since 1998 in both commercial and academic capacities. He was awarded his PhD in 2003 from the University of Waikato in New Zealand, has published >90 papers attracting more than 10,000 citations, and is recipient of several highly competitive awards and fellowships. He is also a founder of two other successful start-up companies. In 2016, Marcel was admitted as a Fellow into the Faculty of Sciences of the Royal College of Pathologists of Australiasia and is a Graduate of the Australian Institute of Company Directors.
                  • Mark Driscoll, PhD
                    Chief Scientific Officer, Co-Founder, Shoreline Biome, LLC
                    Biography
                      Mark has led and supported teams launching transformative new innovations globally at Molecular Stagings and 454 Life Sciences. In 2004, he led the development team at 454 Life Sciences that launched the GS 20, the first of the NGS (Next Generation Sequencing) systems, which revolutionized the world of DNA sequencing. He was part of the development teams that launched the GS FLX, the GS FLX+, and the GS Junior, the first of the benchtop sequencers. Mark has experience leading a development team consisting of subteams in hardware, software, informatics, reagents, marketing, and customer support. Mark received his Ph.D. in Biochemistry from the University of Rochester and his B.S. in Biology from the University of Buffalo.
                    • Steven Gross, PhD
                      Professor of Pharmacology, Director, Advanced Training in Pharmacology, Director, Metabolomics Lab, Weill Cornell Medical College
                      Biography
                        Steven S. Gross, Ph.D., is Professor of Pharmacology, Director of the Mass Spectrometry Core Facility. Dr. Gross' expertise is in pharmacology, and cell and structural biology, particularly in relation to the role of nitric oxide (NO) as a signaling molecule. In the late 1980's, Dr. Gross and colleagues made the initial identification of L-arginine as the precursor of NO in blood vessels. They were also first to establish that NOS inhibition elevates blood pressure in animals, demonstrating that NO plays a physiological role in controlling blood pressure and vascular tone. Since then, research efforts have predominantly focused on elucidating the enzymes and mechanisms that regulate NO synthesis in cells. Results of these basic studies have provided fundamental insights into the therapeutic control of NO synthesis, resulting in core technologies for the creation of ArgiNOx Inc., a biotech start-up that is developing novel NO-based drugs. Dr. Gross has authored or coauthored more than 90 research publications and 40 book chapters, review articles and books in the area of NO biology. He is an active member of NIH Study Sections and is a founder and Board Director of the Nitric Oxide Society, a group that organizes the major annual international meetings on the subject of NO and publishes a peer-reviewed scientific journal with novel reports on NO biology and chemistry. Dr. Gross received his Ph.D. in Biomedical Science from the Mount Sinai School of Medicine in New York City.
                      • Bruce R. Korf, MD, PhD
                        Professor and Chair, Department of Genetics, Director, Heflin Center for Genomic Sciences, UAB
                        Biography
                          Dr. Korf is the Chief Genomics Officer, UAB Medicine, Wayne H. and Sara Crews Finley Endowed Chair in Medical Genetics, Professor of Genetics, Co-Director of the UAB-HudsonAlpha Center for Genomic Medicine, Associate Director for Rare Diseases, Hugh Kaul Personalized Medicine Institute and editor-in-chief of the American Journal of Human Genetics. He is a medical geneticist, pediatrician, and child neurologist, certified by the American Board of Medical Genetics and Genomics (clinical genetics, clinical cytogenetics, and clinical molecular genetics), American Board of Pediatrics, and American Board of Psychiatry and Neurology (child neurology). Dr. Korf is past president of the Association of Professors of Human and Medical Genetics, past president of the American College of Medical Genetics and Genomics, and current president of the ACMG Foundation for Genetic and Genomic Medicine. He has served on the Board of Scientific Counselors of the National Cancer Institute and the National Human Genome Research Institute at the NIH. His major research interests are molecular diagnosis of genetic disorders and the natural history, genetics, and treatment of neurofibromatosis. He serves as principal investigator of the Department of Defense funded Neurofibromatosis Clinical Trials Consortium, the Alabama Genomic Health Initiative, and the Southern All of Us Network. He is co-author of Human Genetics and Genomics (medical student textbook, now in fourth edition), Medical Genetics at a Glance (medical student textbook (now in third edition), Emery and Rimoin's Principles and Practice of Medical Genetics (now in 6th edition), and Current Protocols in Human Genetics.
                        • Jonas Korlach, PhD
                          Chief Scientific Officer, Pacific Biosciences
                          Biography
                            Jonas Korlach was appointed Chief Scientific Officer of Pacific Biosciences in July 2012. He was previously a Scientific Fellow, supporting commercial development of the PacBio RS II system and performing research aimed at developing new applications for SMRT technologies. He co-invented the SMRT technology with Stephen Turner, Ph.D., Pacific Biosciences Founder and Chief Technology Officer, when the two were graduate students at Cornell University. Dr. Korlach joined Pacific Biosciences as the company's eighth employee in 2004. Previously, he was a Postdoctoral Researcher at Cornell University. Dr. Korlach is the recipient of multiple grants, an inventor on 70 issued U.S. patents and 61 international patents, and an author of over 70 scientific studies on the principles and applications of SMRT technology, including publications in Nature, Science, and PNAS. In 2013, Dr. Korlach was honored by the Obama White House as an Immigrant Innovator "Champion of Change." He received both his Ph.D. and his M.S. degrees in Biochemistry, Molecular and Cell Biology from Cornell, and received M.S. and B.A. degrees in Biological Sciences from Humboldt University in Berlin, Germany.
                          • Jessica C. Mar, PhD
                            Assistant Professor, Department of Systems & Computational Biology, Assistant Professor, Department of Epidemiology & Population Health, Albert Einstein College of Medicine
                            Biography
                              Jessica Mar is an Assistant Professor at Albert Einstein College of Medicine in the Department of Systems and Computational Biology in the Bronx, New York. The focus of the Mar lab is to understand how variability in gene expression contributes to the regulation of cellular phenotypes. Around the topic of variability, her work involves applications in single cell genomics, stem cells, genetics and cancer biology. Jessica Mar received her Bachelor of Science degree in Mathematics at the University of Queensland in Brisbane, Australia and First Class Honors in Statistics in 2002. She got her PhD in Biostatistics from Harvard University in 2008. Previously she was a postdoctoral research fellow at the Dana-Farber Cancer Institute in Boston, and a visiting scientist at the European Bioinformatics Institute in the UK. Since July 2016, Dr. Mar holds a joint appointment with the Australian Institute for Bioengineering and Nanotechnology at the University of Queensland, Australia as a Group Leader.
                            • Chris Merritt, PhD
                              Senior Scientist at NanoString Technologies, Inc.
                              Biography
                                Dr. Chris Merritt is a molecular biologist with expertise in developmental biology and cancer research. Currently, he is the lead R&D scientist for developing new multiplexing technologies and lyse-n-go optimized protocols for gene expression analysis, along with many other novel technologies at NanoString. He received his Ph.D. in Molecular Biology and Genetics from the Johns Hopkins School of Medicine where he studied gene expression in the C. elegans germline.
                              • Ryan E. Mills, PhD
                                Assistant Professor, Department of Computational Medicine & Bioinformatics, Assistant Professor, Department of Human Genetics, University of Michigan
                                Biography
                                  Ryan Mills is an Assistant Professor in Computational Medicine & Bioinformatics and Human Genetics at the University of Michigan. After receiving his PhD in 2006 at Georgia Tech, he worked as an NRSA Postdoctoral Fellow at Emory University where he helped produce some of the first published genome-wide maps of insertion/deletion (indel) variation in human populations and develop technologies to derive their genotypes using microarrays. As a Research Associate at Harvard Medical School, he expanded the scope of his work into the mapping of larger structural and copy number variation as part of the 1000 Genomes and other projects. His current research is focused on developing methods for the identification, resolution and analysis of complex and repetitive genomic rearrangements consisting of multiple breakpoints that are the result of overlapping or co-occurring structural changes to the genome. He is also exploring the prevalence of such variation in the context of brain somatic mosaicism in neuropsychiatric disorders.
                                • Juliane Nguyen, PharmD, PhD
                                  Assistant Professor, Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo
                                • Joseph Paulson, PhD
                                  Research Fellow, Dana-Farber Cancer Institute
                                  Biography
                                    I am a Research Fellow in the Department of Biostatistics and Computational Biology at the Dana-Farber Cancer Institute and Department of Biostatistics at the Harvard TH Chan School of Public Health under the guidance of Professor John Quackenbush. Prior to joining Harvard I was a National Science Foundation Graduate Research Fellow at the University of Maryland, College Park where I received my Ph.D. in Applied Mathematics, Statistics and Scientific Computation. As a computer scientist and computational biologist, my interests are to develop computational methods for the analysis of high-throughput sequencing data. I also desire to develop software and support these methods as open-source software for the broader scientific community through Bioconductor and popular domain tools such as QIIME and Phyloseq. MetagenomeSeq, is my most popular tool developed and is in the top 5% of all Bioconductor packages downloaded in the last year with over 5,000 unique users. I am excited to leverage statistical and network methodologies in accounting for technological when identifying disease markers.
                                  • Sigrid Reinsch, PhD
                                    Scientist, Space Biosciences Research Branch, NASA
                                    Biography
                                      Dr. Sigrid Reinsch has expertise in cell and developmental biology and has worked in the Space Biosciences Research Branch at NASA's Ames Research Center since 1998. Prior to NASA, she completed a Ph.D. in Cell Biology at the University of California San Francisco and a post-doctoral fellowship at the European Molecular Biology Laboratory in Heidelberg, Germany. She currently serves as a Senior Scientist on NASA's GeneLab Project, which capitalizes on multi-omic technologies to maximize the return on spaceflight experiments. The GeneLab project houses spaceflight and spaceflight relevant multi-omics data in a publicly accessible data commons, and collaborates with NASA-funded principal investigators to enable omics analyses on their experiments.
                                    • Kevin Roy, PhD
                                      Postdoctoral Scholar, Department of Genetics, Stanford University
                                      Biography
                                        Kevin obtained his Ph.D. at UCLA in the laboratory of Guillaume Chanfreau, where he studied RNA biology and developed high-throughput sequencing methods to map RNA degradation intermediates genome-wide. He is currently a National Research Council (NRC) postdoctoral associate in the laboratories of Dr. Lars Steinmetz at Stanford University and Dr. Marc Salit at the the Joint Initiative for Metrology in Biology (JIMB), a joint institute between Stanford University and the National Institute of Standards and Technology (NIST). Kevin works on developing high-throughput precision genome editing technologies with CRISPR/Cas9 to enable dissecting the genetic architecture underlying complex cellular phenotypes.
                                      • Ina Scheuerpflug, PhD
                                        Director of Global Marketing, Life Science, QIAGEN
                                        Biography
                                          Ina is a Director of Global Marketing, Life Science at QIAGEN. She received her PhD from the Max Planck Institute for Biology, studying bacterial pilus adhesion and interaction with the human host receptor/signaling pathway, and publishing a number of scientific publications. At QIAGEN, she is focused on gene expression and gene regulation on a global level and has a keen interest in the emerging field of gene expression studies.
                                        • Verena Schramm, PhD
                                          Global Product Manager, QIAGEN
                                          Biography
                                            Dr. Verena Schramm is a Global Product Manager for RNA sample extraction and Liquid Biopsy at QIAGEN GmbH, Germany. Before taking over these product responsibility, she was a Global Product Manager for NGS library preparation products at QIAGEN. Verena holds and M.Sc. in Molecular Biology and a PhD in Bioinformatics. During her PhD at EMBL Heidelberg she studied the impact of copy-number variation during the evolution of non-human primates using Next-Generation Sequencing. Before joining QIAGEN, Verena worked as a Sales and Business Development Manager DACH, NL and as a Subject Matter Expert at Sophia Genetics a company focusing on the analysis of clinical NGS data in Diagnostics.
                                          • Fritz Sedlazeck, PhD
                                            Lead Scientific Programmer, Baylor College of Medicine
                                            Biography
                                              Dr. Fritz Sedlazeck completed his PhD in 2012 in the group of Dr. Arndt von Haeseler at the Max F. Perutz Laboratory in Vienna. After a two year postdoc, he transitioned to the lab of Dr. Michael Schatz at Cold Spring Harbor Laboratory and later to Johns Hopkins University. Since 2017 he leads his own group at the Human Genome Sequencing Centre at Baylor College of Medicine. His research focuses on developing computational methods to detect and analyse genomic variations with a focus on Structural Variations. Structural Variations are genomic events that manipulate multiple positions in a genome, which impact evolution, genomic disorders, regulation as well as play an important role in explaining multiple phenotypes.
                                            • Amy Turner, BS
                                              Research Associate I, Project Leader - miRNA Technologies, Section of Genomic Pediatrics, Department of Pediatrics, Medical College of Wisconsin
                                              Biography
                                                Amy is a Research Associate at the Medical College of Wisconsin and has spent the last ten years working on both research and clinical diagnostic testing in the laboratory of Dr. Ulrich Broeckel. Her primary interest is in transnational research, in particular in the area of left ventricular hypertrophy (LVH). By combining genetic information with functional analysis utilizing hiPSC-Cardiomyocytes (NGS expression analysis, proteomics, etc.), her goal is to provide novel insights into the complex regulatory role of miRNAs, both intracellular and exosomal, in the development of cardiovascular dysfunction and how genetic variation affects this. Her other research interests are in Pharmacogenomics, TKI induced cardiotoxicity, the role of extracellular matrix on cardiovascular function in disease, and studying the impact of post translational RNA editing on protein function.
                                              • Justin Zook, PhD
                                                Research Scientist, NIST
                                              Sponsored By

                                              For information on becoming a sponsor or exhibitor, please click here.


                                              C.E. Credits

                                              The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here

                                              Please check back a couple days before the live event to see who has been approved for PACE CE, CME and CEU credits.

                                               

                                              The presentational method for this activity will be Lecture with an opportunity for real-time question and answer periods for the live activity, and on demand access of the presentation for the enduring material activity. Both the internet live course and the internet activity enduring material are geared towards Primary Care Clinicians, all Health Care Professionals, including Genetic Counselors, PAs, LPNs, NPs, RNs, Clinical Geneticists, Physicians in practice, Genetics Researchers, and others. This activity will encompass the following desirable physician attributes:  Patient Care & Procedural Skills, Medical Knowledge, Professionalism, and Systems-Based Practice.

                                              Desired Outcomes

                                              1. At the end of the activity, participants should be able to:
                                              2. Integrate genetic medicine into practice in ways that are consistent with acknowledged practice guidelines and that improve patient management and outcomes
                                              3. Integrate genetic technologies currently available for use in the clinic and the limitations of these technologies
                                              4. Apply current and established medical science principles to patient care, including utilization of information in personal and family histories that indicate a need for genetic testing
                                              5. Perform continuous self-assessment and learning to improve one’s professional and clinical practices, including how to interpret results in ways most useful to the patient and when to refer to specialized genetic services

                                              This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME®) through the joint providership of CME Consultants and LabRoots. CME Consultants is accredited by the ACCME® to provide continuing medical education for physicians.

                                              CME Consultants designates this internet live activity for a maximum of 7.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

                                              CME Consultants designates this internet live activity enduring material for a maximum of 7.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

                                              Enduring Material release date: 5/11/18

                                              Enduring Material Termination date: 8/11/18

                                              In accordance with the Americans with Disability Act (ADA), please contact LabRoots at ce@labroots.com should you require special assistance.


                                              Committee

                                              To download the Program Committee brochure here.


                                              • Timothy Harris, PhD

                                                Since June 2011, Dr. Harris has served as the Senior Vice President of Translational Medicine at Biogen Idec. Dr. Harris has served as the Director of the Advanced Technology Program at SAIC Frederick since 2007 and Chief Technology Officer for SAIC Frederick since 2008. Prior to ...

                                                See more See less
                                              • Agnieszka Lichanzka Ph.D.

                                                Agnieszka is currently a Staff Scientist and Laboratory Manager at TessArae, LLC in Sterling, VA, USA. She obtained her PhD at the University of Queensland in Australia in a field of biochemistry, and subsequently worked as a post-doctoral fellow at Queen's University of Belfast ...

                                                See more See less
                                              • Charles Cantor, PhD

                                                Dr. Charles Cantor is a founder, and Chief Scientific Officer at SEQUENOM, Inc., which is a genetics discovery company with tools, information and strategies for determining the medical impact of genes and genetic variations. He is also the founder of SelectX Pharmaceuticals ...

                                                See more See less
                                              • John Quackenbush, PhD

                                                John Quackenbush received his PhD in 1990 in theoretical physics from UCLA working on string theory models. Following two years as a postdoctoral fellow in physics, Dr. Quackenbush applied for and received a Special Emphasis Research Career Award from the National Center for ...

                                                See more See less
                                              • Shawn Baker, PhD

                                                Dr. Shawn C. Baker is the Chief Science Officer and co-founder of AllSeq. Having received his Ph.D. at the University of California - Davis, he started his career as a Research Scientist at Illumina when it was a 15-person startup. After spending several years at the bench ...

                                                See more See less
                                              • Alexander Zaranek, PhD

                                                Alexander (Sasha) Wait Zaranek, PhD is co-founder and Chief Scientist at Curoverse, a venture-backed company focused on building a free and open-source platform for storing, analyzing and sharing biomedical data. Sasha works on open technologies that are part of the revolution ...

                                                See more See less
                                              • Molly McGinniss

                                                Molly McGinniss, MS, LCGC is a Senior Market Development Manager for Illumina's "Healthy Genome Initiatives" team. Her current role focuses on advancing the use of whole genome sequencing in clinical care by providing access and education to healthy individuals through the ...

                                                See more See less
                                              • Sarah Murray

                                                Dr. Murray is Director of Genomic Technologies at UC San Diego's Center for Advanced Laboratory Medicine (CALM) and Professor in the Department of Pathology. At the CALM, Dr. Murray is involved with the development of advanced genomic technologies for the clinical lab, and ...

                                                See more See less
                                              • Weida Tong, PhD

                                                Dr. Tong is Director of Division of Bioinformatics and Biostatistics at FDA's National Center for Toxicological Research (NCTR/FDA). He has served a science advisory board member for several large projects involving multiple institutes in Europe and USA. He also holds several ...

                                                See more See less
                                              • Jonas Korlach, PhD

                                                Jonas Korlach was appointed Chief Scientific Officer of Pacific Biosciences in July 2012. He was previously a Scientific Fellow, supporting commercial development of the PacBio RS II system and performing research aimed at developing new applications for SMRT technologies. He ...

                                                See more See less
                                              Help

                                              General LabRoots Questions

                                              For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                                              Contact us

                                              Virtual Events and Webinars

                                              Supported Configurations

                                              • Operating System Internet Explorer Firefox Chrome Safari
                                                Vista IE8+ FF10+ Chrome15+
                                                Windows 7 IE8+ FF10+ Chrome15+
                                                Windows 8 IE10 FF10+ Chrome15+
                                                Mac OS X   FF10+ Chrome15+ Safari5.1+
                                              • Cookie settings: session cookies enabled
                                              • Browser configuration must have JavaScript enabled
                                              • Adobe Flash player 10.2 or later

                                              To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                              Internet Connection

                                              • A minimum of 100Kbps is recommended for audio-only events
                                              • A minimum of 300Kbps is recommended for speaker on-video events

                                              Computer Equipment

                                              • Screen Resolution: Minimum 1024x768
                                              • Video Card: 65,000 colors minimum
                                              • Sound card and speakers (or headphones) for hearing webcast in full format
                                              • Audio Card: 16-bit minimum
                                              • RAM: 512MB of free RAM

                                              Firewall Protocol

                                              • HTTP on port 80 or HTTPS on port 443
                                              • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                              • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                              Work-At-Home Attendees

                                              • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                              For A Seamless Experience

                                              When using a mobile device, FREE Mobile Apps are available:

                                              - For viewing Webinars:

                                              - For viewing Virtual Events

                                              Attendee Guide

                                              • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                              Virtual Event and Webinar Support:

                                              Continuing Education (CME/CE) Support

                                              Loading Comments...